jeff
Botox to be tested for Treating Cold Sores
A treatment used to get rid of wrinkles is being used for other purposes as well. Apparently, Botox is being used to treat the cold sores that occur in people suffering from the herpes simplex virus. The sores usually appear around the lips of people suffering from the condition. Though, the infection does not appear […]
Botox Shots Approved for Migraine
The Food and Drug Administration approved Botox, the anti-wrinkle shot from Allergan, as a treatment to prevent chronic migraines, a little more than a month after the company agreed to pay $600 million to settle allegations that it had illegally marketed the drug for unapproved uses like headaches for years. Allergan says sales of Botox […]
IAPAM Supports Physicians as they Capitalize on $121 Billion Weight Loss Market
The IAPAM’s hCG Training for Physicians provides doctors with all the education and resources they need to capture a portion of the $3.6 billion dollar market for weight management pharmaceuticals. Over 350 physicians have attended the IAPAM’s hCG Training in 2010, and are now poised to capture the “2011 New Year Resolution” market for loosing weight. […]
Non-Surgical Aesthetic Enhancement with Bodily Energy Modulation: New Frontiers of Energy and Cosmetic Medicine
Part 1: Introduction Acupuncture has been clinically defined in a variegated manner by energy medical practitioners. H.H. Moffet 2009 review study powerfully demonstrated that Sham acupuncture is as efficacious as traditional acupuncture techniques. This researcher utilized 229 articles showing that non-Chi channel points were as therapeutic as traditional methodologies. He writes the following: “this study […]
FDA Says No — At Least for Now — to Arena’s Weight-Loss Pill – lorcaserin
Arena Pharmaceuticals said early Saturday morning that the FDA won’t approve the company’s weight-loss drug lorcaserin without further data to support the drug’s efficacy and safety. That wasn’t a terribly big surprise, given that an outside FDA advisory panel last month voted not to recommend approval. The FDA has questions about the possibility of a […]
Hasta La Vista, Meridia: Another Diet Drug Bites the Dust
Abbott’s removal of Meridia from the U.S. market — at the FDA’s request — means there’s just one weight-loss therapy approved for long-term use in a country where 68% of the population is overweight or obese. (As the WSJ reports, Abbott also pulled the drug in Canada and Australia today. Regulators removed Meridia from the […]
IAPAM’s hCG Program Includes Enhanced Weight Loss Maintenance Strategies
The IAPAM’s hCG Physician Weight Loss Program offers physicians all the resources and training they need to add hCG for Weight Loss to their practices. Now the IAPAM’s program includes enhanced education on long term weight loss maintenance strategies. The IAPAM is committed to educating physicians on the best practices for using hCG as part of […]
IAPAM’s hCG Training Prepares Physicians for Weight Loss Resolutions
The IAPAM’s December 3rd session of its comprehensive hCG Physician Weight Loss Training program is the final hCG Training Session of 2010. For physicians who want to add hCG for Weight Loss to their practices in preparation for the flood of patients on January 1, 2011, attendance at the December 3rd seminar is the last chance to […]
Learn from Leading Dermatologists at IAPAM’s Symposium with Botox Training
The IAPAM continues to offer the industry’s best clinical, hands-on, aesthetic medicine training in the most advanced skin care procedures. The IAPAM’s Aesthetic Medicine Symposium is a weekend training program, designed by physicians for physicians, and supports the addition of the top 5 minimally invasive procedures: botox, dermal fillers, lasers, microdermabrasion, chemical peels and hCG […]
Xeomin® (incobotulinumtoxinA) – a Botulinum Toxin Free From Accessory Proteins – Now Available in the U.S.
Merz Pharmaceuticals announced that Xeomin® (incobotulinumtoxinA), a new botulinum toxin type A for the treatment of adults with cervical dystonia (CD) or blepharospasm, is now commercially available in the U.S. XEOMIN was approved by the U.S. Food and Drug Administration (FDA) on July 30, 2010. XEOMIN is a botulinum toxin type A that is free […]
